Hello and welcome to episode 174 of the Juice Box Podcast.

Today's episode is with Mike Menzinger.

Mike was once a long time employee of Dexcom,

but he has gone on his own to develop a smart pen.

See MDI users, I got you covered. Please remember that nothing you hear on the juice box podcast should be considered

advice medical or otherwise. Always consult a physician before making changes to

your health care plan. Hi Scott I'm Mike Minsinger, I'm Chief Technology Officer at Companion Medical.

Great to talk to you again.

Yeah, I appreciate you coming back on now with a different company though.

Yeah, the LeftXcom about a year and a half ago and what an amazing journey that was with Dexcom

Share and G5 and it was such a privilege to be part of all of that transformation in diabetes technology and happy to do it again in the injection therapy now.

That's pretty exciting. So how long were you at that's come?

13 and a half years. So years started in 2003 and my co-founder Sean Saint is the CEO

he actually built the first Dexcom short-term sensor in 2004 so we have a lot of early Dexcom heritage here.

And so now you and Sean are on a different path trying something different.

Yeah, the, you know, while the technology was really amazing and it was really great to be part of everything we did at Dexcom, we were frustrated at the lack of technology that was directed towards the injection market.

So there's so many great solutions today that's available for insulin pump users.

It's very exciting to see, but comparatively nothing available today for injection users.

It really did feel like, and does feel like, honestly, that people using pumps have access

to so much more data and technology.

And I don't know if it's a left-behind situation or where it was headed but it really did feel like

There was a chasm growing between people who wanted to do MDI and people who wanted to pump and the people who were

...